| Absorption |
| Blood-Brain Barrier | BBB- | 0.9681 |
| Human Intestinal Absorption | HIA+ | 0.9334 |
| Caco-2 Permeability | Caco2+ | 0.5255 |
| P-glycoprotein Substrate | Substrate | 0.6686 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8231 |
| Non-inhibitor | 0.6452 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9495 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6921 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7627 |
| CYP450 2D6 Substrate | Non-substrate | 0.8789 |
| CYP450 3A4 Substrate | Substrate | 0.7128 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8800 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8887 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9184 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8765 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7757 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6354 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9965 |
| Non-inhibitor | 0.6655 |
| AMES Toxicity | Non AMES toxic | 0.8464 |
| Carcinogens | Non-carcinogens | 0.8767 |
| Fish Toxicity | High FHMT | 0.9822 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9682 |
| Honey Bee Toxicity | Low HBT | 0.7055 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6186 |
| Carcinogenicity (Three-class) | Non-required | 0.6525 |